Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18809327rdf:typepubmed:Citationlld:pubmed
pubmed-article:18809327lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18809327lifeskim:mentionsumls-concept:C1421467lld:lifeskim
pubmed-article:18809327lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18809327lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:18809327lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:18809327lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:18809327pubmed:issue20lld:pubmed
pubmed-article:18809327pubmed:dateCreated2008-10-20lld:pubmed
pubmed-article:18809327pubmed:abstractText6-Phenylnicotinamide (2) was previously identified as a potent TRPV1 antagonist with activity in an in vivo model of inflammatory pain. Optimization of this lead through modification of both the biaryl and heteroaryl components has resulted in the discovery of 6-(4-fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide (32; SB-782443) which possesses an excellent overall profile and has been progressed into pre-clinical development.lld:pubmed
pubmed-article:18809327pubmed:languageenglld:pubmed
pubmed-article:18809327pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:citationSubsetIMlld:pubmed
pubmed-article:18809327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18809327pubmed:statusMEDLINElld:pubmed
pubmed-article:18809327pubmed:monthOctlld:pubmed
pubmed-article:18809327pubmed:issn1464-3405lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:DavisJohn BJBlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:GunthorpeMart...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:WrightJamesJlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:StevensAlexan...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:StempGeoffrey...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:MedhurstSteph...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:JermanJeffrey...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:WinbornKim...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:ColemanTanyaTlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:MitchellDarre...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:ThompsonMervy...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:RamiHarshad...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:WestawaySusan...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:HollandVickyVlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:SealJon TJTlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:LappinSarah...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:ArpinoSandraSlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:TrouwLeontine...lld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:BiggsJamesJlld:pubmed
pubmed-article:18809327pubmed:authorpubmed-author:CryanJennifer...lld:pubmed
pubmed-article:18809327pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18809327pubmed:day15lld:pubmed
pubmed-article:18809327pubmed:volume18lld:pubmed
pubmed-article:18809327pubmed:ownerNLMlld:pubmed
pubmed-article:18809327pubmed:authorsCompleteYlld:pubmed
pubmed-article:18809327pubmed:pagination5609-13lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:meshHeadingpubmed-meshheading:18809327...lld:pubmed
pubmed-article:18809327pubmed:year2008lld:pubmed
pubmed-article:18809327pubmed:articleTitleDesign and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1.lld:pubmed
pubmed-article:18809327pubmed:affiliationNeurology CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. sue.m.westaway@gsk.comlld:pubmed
pubmed-article:18809327pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18809327lld:chembl